CSIRO Publishing blank image blank image blank image blank imageBooksblank image blank image blank image blank imageJournalsblank image blank image blank image blank imageAbout Usblank image blank image blank image blank imageShopping Cartblank image blank image blank image You are here: Journals > New South Wales Public Health Bulletin   
New South Wales Public Health Bulletin
http://www.health.nsw.gov.au
  Supporting public health practice in New South Wales
 
blank image Search
 
blank image blank image
blank image
 
  Advanced Search
   

Journal Home
Content

red arrow Cumulative Indexes
blank image
Cumulative Subject Index Cumulative Author Index

red arrow Connect with CP
blank image
facebook twitter youtube

 

Article << Previous     |     Next >>   Contents Vol 21(4)

The effectiveness of harm reduction in preventing HIV among injecting drug users

Alex Wodak A C, Lisa Maher B

A Alcohol and Drug Service, St Vincent’s Hospital, Darlinghurst NSW
B National Centre in HIV Epidemiology and Clinical Research, Darlinghurst NSW
C Corresponding author. Email: awodak@stvincents.com.au
 
 Full Text
 PDF (73 KB)
 Export Citation
 Print
  


Abstract

There is now compelling evidence that harm reduction approaches to HIV prevention among injecting drug users are effective, safe and cost-effective. The evidence of effectiveness is strongest for needle and syringe programs and opioid substitution treatment. There is no convincing evidence that needle and syringe programs increase injecting drug use. The low prevalence (~1%) of HIV among injecting drug users reflects the early adoption and rapid expansion of harm reduction in Australia. Countries that have provided extensive needle and syringe programs and opioid substitution treatment appear to have averted an epidemic, stabilised or substantially reduced the prevalence of HIV among injecting drug users. However, despite decades of vigorous advocacy and scientific evidence, the global coverage of needle and syringe programs and opioid substitution treatment falls well short of the levels required to achieve international HIV control.

   
    
Legal & Privacy | Contact Us | Help

CSIRO

© CSIRO 1996-2014